Figures computed from official regulatory filings — .
Ownershipinsiders 89.3% · institutions 6.67%
In EUR · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Dermapharm Holding SE only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.
Market information source · Oct 19, 2026
Open-market timeline · full history
5 buys— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Themis Beteiligungs-Aktiengesellschaft | Buy | $20.8M | conv 21 | BAFIN |
| Christof Dreibholz | Buy | $112K | conv 36First in 12mo | BAFIN |
| Themis Beteiligungs-Aktiengesellschaft | Buy | $62.6M | conv 12 | BAFIN |
| Themis Beteiligungs-Aktiengesellschaft | Buy | $41.8M | conv 23First in 12mo | BAFIN |
| Wilhelm Beier | Buy | $4.1M | conv 36First in 12mo | BAFIN |